Market News
Stay updated with the latest market trends, earnings, and economic indicators.
HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings
Motilal Oswal Healthcare Foundation, and Motilal Oswal Foundation were sellers in Motilal Oswal Financial Services shares.
Neutral Indegene; target of Rs 552: Motilal Oswal
Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.
Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal
Motilal Oswal is bullish on Dr Agarwals Health Care recommended buy rating on the stock with a target price of Rs 610 in its research report dated Jun 05, 2026.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal is bullish on Five Star Business Finance has recommended buy rating on the stock with a target price of Rs 600 in its research report dated April 29, 2026.
Buy Granules India; target of Rs 820: Motilal Oswal
Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.
Buy Star Health; target of Rs 640: Motilal Oswal
Motilal Oswal is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 640 in its research report dated April 29, 2026.
PSL offloads 0.6% stake in Sun Pharma Advanced Research, Motilal Oswal buys additional 0.7% stake in Adisoft
Sun Pharma Advanced Research Company shares fell 3.72 percent to Rs 143.04 amid high volumes
Buy Rubicon Research; target of Rs 955: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 955 in its research report dated April 15, 2026.
Closing Bell: Nifty crosses 24,200, Sensex surges 1,264 pts on renewed hopes of US-Iran peace talks
Interglobe Aviation, Max Healthcare, Power Grid Corp, Wipro, Eternal were among biggest gainers on the Nifty, while losers were Dr Reddy's Laboratories, Bharti Airtel, ICICI Bank. All the sectoral indices ended in the green with Capital Goods, Oil & Gas, Power, Infra, Media, Realty, Consumer Durables, IT rise 2% each. Nifty Midcap and Smallcap indices up more than 2 percent each.
Closing Bell: Nifty above 23,100, Sensex gain 509 pts; IT, metal, realty shine
Biggest Nifty gainers were Wipro, Hindalco Industries, HCL Technologies, TCS, Infosys, while losers included Dr Reddy's Laboratories, Adani Enterprises, Interglobe Aviatoion, Apollo Hospitals, Adani Ports. Except Consumer Durables and PSU Bank, all other sectoral indices ended in the green with Information Technology rose 2.5%, Metal index gained 1.5%, Realty index up 1.7% and Media index jumped 1%. The Nifty midcap index was up 0.3 percent, while smallcap index ended flat.